AAgilent Technologies Inc.
$135.38
$0.10
(0.07%)
Pre-Market
Reported EarningsMay 27
Mkt Cap$38.26B
Vol455.00
Fundamentals
Mkt Cap
$38.26B
Volume
-
52W High
$160.27
52W Low
$108.35
PE Ratio
27.21
Avg. Volume
2.63M
EPS (Annual)
$4.57
Rev/Employee
$383,867.40
Earnings
May 27
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the companys products, operations, and customer workflows. AI is a top priority, and this partnership reflects both...
Business Wire
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the expanded use of PD-L1 IHC 22C3 pharmDx, Code GE006, for use on the Dako Omnis platform to aid in identifying patients in the United States with esophageal squamous cell carcinoma...
Business Wire
Agilent (A) Reliance on International Sales: What Investors Need to Know
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Zacks
Agilent Q2 Earnings Call Shows Ignite Driving a Higher Outlook
A beat Q2 estimates and raised its fiscal 2026 outlook. It says its Ignite operating system is driving more durable gains in pricing, execution and margins.
Zacks
Why Agilent Technologies Stock Triumphed on Thursday
Key PointsThe healthcare solutions specialist is also on track to top analyst estimates for the full year...
Nasdaq News: Markets
Agilent Technologies Q2 Earnings Beat Estimates, Revenues Up Y/Y
A beats Q2 earnings and revenue estimates as recurring revenue hits 66% of sales, but shares lost despite raised fiscal 2026 guidance.
Zacks
Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory
Agilent Technologies Inc. (NYSE: A) today announced the introduction of OpenLab Sync, a new Lab Execution System (LES) that enables laboratories to digitally connect scientific workflows from method design through execution at the bench. OpenLab Sync extends Agilents OpenLab laboratory informatics...
Business Wire
Agilent (A) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Agilent Technologies (A) Tops Q2 Earnings and Revenue Estimates
Agilent (A) delivered earnings and revenue surprises of +6.21% and +2.12%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.83 billion for the second quarter ended April 30, 2026, representing growth of 10.0% reported and up 6.3% core(1) compared with the second quarter of 2025. Second-quarter GAAP net income was $339 million, or $1.20 per share. This...
Business Wire
<
1
2
...
>
Advertisement|Remove ads.
Latest A News
ViewAgilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
Business Wire
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
Business Wire
Agilent (A) Reliance on International Sales: What Investors Need to Know
Zacks
Advertisement|Remove ads.